Cellular iron governs the host response to malaria.
Journal article
Wideman SK. et al, (2023), PLoS pathogens, 19
Erythrocyte invasion-neutralising antibodies prevent Plasmodium falciparum RH5 from binding to basigin-containing membrane protein complexes.
Journal article
Jamwal A. et al, (2023), eLife, 12
Respiratory mucosal immune memory to SARS-CoV-2 after infection and vaccination.
Journal article
Mitsi E. et al, (2023), Nature communications, 14
The dual action of human antibodies specific to Plasmodium falciparum PfRH5 and PfCyRPA: Blocking invasion and inactivating extracellular merozoites.
Journal article
Weiss GE. et al, (2023), PLoS pathogens, 19
A systematic analysis of the human immune response to Plasmodium vivax
Journal article
Bach FA. et al, (2023), Journal of Clinical Investigation
Superior antibody immunogenicity of a viral-vectored RH5 blood-stage malaria vaccine in Tanzanian infants as compared to adults.
Journal article
Silk SE. et al, (2023), Med (New York, N.Y.)
Assessment of precision in growth inhibition assay (GIA) using human anti-PfRH5 antibodies.
Journal article
Miura K. et al, (2023), Malaria journal, 22
Delayed boosting improves human antigen-specific Ig and B cell responses to the RH5.1/AS01B malaria vaccine
Journal article
Nielsen CM. et al, (2023), JCI Insight, 8
Production of a high purity, C‐tagged hepatitis B surface antigen fusion protein VLP vaccine for malaria expressed in Pichia pastoris under cGMP conditions
Journal article
Mukhopadhyay E. et al, (2022), Biotechnology and Bioengineering, 119, 2784 - 2793
Modular capsid decoration boosts adenovirus vaccine-induced humoral immunity against SARS-CoV-2.
Journal article
Dicks MDJ. et al, (2022), Molecular therapy : the journal of the American Society of Gene Therapy
Streptococcus pneumoniae colonization associates with impaired adaptive immune responses against SARS-CoV-2.
Journal article
Mitsi E. et al, (2022), The Journal of clinical investigation, 132
Heterotypic interactions drive antibody synergy against a malaria vaccine candidate.
Journal article
Ragotte RJ. et al, (2022), Nature communications, 13
Expanding the Malaria Antibody Toolkit: Development and Characterisation of Plasmodium falciparum RH5, CyRPA, and CSP Recombinant Human Monoclonal Antibodies.
Journal article
Nacer A. et al, (2022), Frontiers in cellular and infection microbiology, 12
Repeat controlled human malaria infection of healthy UK adults with blood-stage Plasmodium falciparum: Safety and parasite growth dynamics.
Journal article
Salkeld J. et al, (2022), Frontiers in immunology, 13
RH5.1-CyRPA-Ripr antigen combination vaccine shows little improvement over RH5.1 in a preclinical setting.
Journal article
Healer J. et al, (2022), Frontiers in cellular and infection microbiology, 12
The challenges of Plasmodium vivax human malaria infection models for vaccine development.
Journal article
Roobsoong W. et al, (2022), Frontiers in immunology, 13
Understanding the role of serological and clinical data on assessing the dynamic of malaria transmission: a case study of Bagamoyo district, Tanzania.
Journal article
Mwamlima TG. et al, (2022), The Pan African medical journal, 43
Controlled human malaria infection with a clone of Plasmodium vivax with high-quality genome assembly
Journal article
Minassian AM. et al, (2021), JCI Insight, 6
Human Basigin (CD147) Does Not Directly Interact with SARS-CoV-2 Spike Glycoprotein.
Journal article
Ragotte RJ. et al, (2021), mSphere, 6
Antibodies from malaria-exposed Malians generally interact additively or synergistically with human vaccine-induced RH5 antibodies.
Journal article
Willcox AC. et al, (2021), Cell reports. Medicine, 2